These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 35059624)
21. Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial. Mir SA; Ara R; Amin F; Malik A; Hamid L; Ali T; Bader GN; Wani SUD; Almuqbil M; Alshehri S; Alshehri AM; Shakeel F Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363460 [TBL] [Abstract][Full Text] [Related]
22. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs). Musa MA; Khan MO; Cooperwood JS Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144 [TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed. Uray IP; Brown PH Recent Results Cancer Res; 2011; 188():147-62. PubMed ID: 21253797 [TBL] [Abstract][Full Text] [Related]
24. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7. Diel P; Olff S; Schmidt S; Michna H Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969 [TBL] [Abstract][Full Text] [Related]
25. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments. Kloosterboer HJ; Ederveen AG J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712 [TBL] [Abstract][Full Text] [Related]
26. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Chang BY; Kim SA; Malla B; Kim SY Toxicol Res; 2011 Jun; 27(2):85-93. PubMed ID: 24278556 [TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents. Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231 [TBL] [Abstract][Full Text] [Related]
28. Anti-cancer potential of a novel SERM ormeloxifene. Gara RK; Sundram V; Chauhan SC; Jaggi M Curr Med Chem; 2013; 20(33):4177-84. PubMed ID: 23895678 [TBL] [Abstract][Full Text] [Related]
29. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells. Alsous L; Bardaweel S Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). Lewis-Wambi JS; Jordan VC Breast Dis; 2005-2006; 24():93-105. PubMed ID: 16917142 [TBL] [Abstract][Full Text] [Related]
31. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Werner HM; Franke HR; Vermes I Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761 [TBL] [Abstract][Full Text] [Related]
33. Selective Estrogen Receptor Modulators. An KC Asian Spine J; 2016 Aug; 10(4):787-91. PubMed ID: 27559463 [TBL] [Abstract][Full Text] [Related]
34. Selective estrogen receptor modulator ormeloxifene suppresses embryo implantation via inducing miR-140 and targeting insulin-like growth factor 1 receptor in rat uterus. Sirohi VK; Gupta K; Kumar R; Shukla V; Dwivedi A J Steroid Biochem Mol Biol; 2018 Apr; 178():272-282. PubMed ID: 29330027 [TBL] [Abstract][Full Text] [Related]
35. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma. Kriplani A; Srivastava A; Kulshrestha V; Kachhawa G; Agarwal N; Bhatla N; Hari S J Obstet Gynaecol Res; 2016 Dec; 42(12):1744-1752. PubMed ID: 27647770 [TBL] [Abstract][Full Text] [Related]
37. NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity. Kim HI; Kim T; Kim JE; Lee J; Heo J; Lee NR; Kim NJ; Inn KS Int J Oncol; 2015 Jul; 47(1):280-6. PubMed ID: 25964080 [TBL] [Abstract][Full Text] [Related]
38. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination. Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900 [TBL] [Abstract][Full Text] [Related]
39. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues. Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113 [TBL] [Abstract][Full Text] [Related]
40. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Patel HK; Bihani T Pharmacol Ther; 2018 Jun; 186():1-24. PubMed ID: 29289555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]